Evidence-Based Reviews

Worried about high-dose prescribing? Manage risk for you and your patient

Author and Disclosure Information

 

References

“I have explained to the patient the reasons for prescribing the above medication, the expected benefits and potential side effects, the treatment alternatives and possible risks and benefits of the alternatives, and the expected course w/o treatment. The patient asked appropriate questions and appeared to understand the answers. (I discussed off-label use.) I provided information from the manufacturer (or some other source). The patient has decided to try this medication and to be followed.”

Caveats. Avoid “cutting and pasting” language for each informed consent discussion into each medical record. Make your discussion and its documentation reflect each individual’s treatment plan. If you use a preprinted consent/medications side-effect form (as required by many institutions and clinics), consider entering a personalized notation into the progress notes as needed, such as when:

  • you prescribe medications with high risk for serious side effects
  • you use off-label prescribing that is not customary
  • a patient needs extra assistance to follow the treatment plan.8
The procedure’s formality helps a patient focus on the consent process, making it less likely that he/she will later believe he/she was not adequately informed. The signed form supports the assertion that the consent process took place and establishes at least some of what was disclosed. The signed form and the clinician’s entry in the record documenting the informed consent discussion will be beneficial should malpractice litigation allege consent issues.

Table 2

Informed consent: Pertinent points to document

Proposed treatment
Potential side effects (most common)
Potential side effects (most dangerous)
Potential side effects that might make a patient anxious, such as those included in recent FDA statements, changes in labeling, or advertisers’ consumer marketing messages
Alternatives, including their potential side effects
Course without treatment
Demonstration of patient’s comprehension of warnings and opportunity to ask questions
Preprinted forms. A disadvantage of preprinted forms is the difficulty in knowing what information to include. If the form’s content is very broad, then important information may not be disclosed. If the form is very specific and attempts to list all possible complications, one could presume that any complication not listed was not disclosed. If you incorporate an informed consent form into your practice:
  • include all significant and material risks on the form
  • state on the form that the risks “include, but are not limited to” those listed on the form
  • have thorough informed consent discussions with patients
  • enter into the medical record your discussion and a copy of the form signed by the patient.
What to disclose. Clinicians often struggle with how much information to disclose to patients. In general, include what a reasonable person would need to know to make an informed decision. A practical way to think about this is to ask yourself the following questions:
  • What information would I want a physician to disclose to my loved one (parent, child, spouse, etc.) if I was not present and my loved one needed to give consent to a treatment recommendation?
  • Is this information of the type that a reasonable person could say: “I wouldn’t have consented if the doctor had told me that”? If you think so, then provide this information to your patient.
Patient resources. Medication information sheets can enhance informed consent and patients’ understanding and retention of information about medications you prescribe. The FDA’s Web site (www.fda.gov) offers printable patient education sheets on hundreds of medications, medication guides, and other resources (see Related Resources).6 Many manufacturers also offer patient education information at their Web sites, via pharmaceutical representatives, and as part of the PI.

Related resources

Drug brand names
  • Aripiprazole • Abilify
  • Olanzapine • Zyprexa
  • Quetiapine • Seroquel
  • Risperidone • Risperdal
  • Ziprasidone • Geodon
Disclosures

Dr. Kaye receives research support from Pfizer Inc. and Takeda Pharmaceutical and is a consultant to and speaker for Pfizer Inc., AstraZeneca, and GlaxoSmithKline.

Jacqueline Melonas is a full-time employee of PRMS, Inc. PRMS, Inc. contracts with Eli Lilly and Company to provide risk management content related to the management of medical malpractice liability.

Pages

Recommended Reading

Tailor Outreach to Elderly Disaster Survivors
MDedge Psychiatry
Entacapone Blunts Cravings in Marijuana Users
MDedge Psychiatry
Vouchers Can Help Pregnant Smokers Abstain
MDedge Psychiatry
Access to Heroin a Boon to Refractory Addicts
MDedge Psychiatry
Internet-Based Interventions Can Help Youth
MDedge Psychiatry
Policy & Practice
MDedge Psychiatry
FYI
MDedge Psychiatry
No EMR? Try the Bird in Hand
MDedge Psychiatry
Compulsive bruxism: How to protect your patients’ teeth
MDedge Psychiatry
Is fibromyalgia a somatoform disorder?
MDedge Psychiatry